Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

EpiPen Familiarity May Prove Tough Hurdle For Generics

Sep 12 2016

• By Derrick Gingery

EpiPen

Related Content

Mylan’s EpiPen Defense Against Generics Focuses On Device Design

Jan 22 2015

<em>Zarxio</em> Syringe’s Limitations May Delay Decision On <em>Neupogen</em> Interchangeability

Jun 15 2015

Mylan’s EpiPen Exclusivity Saved Again As Teva Reports CRL

Mar 01 2016

Biosimilars' Pediatric Pressures Could Push Them Toward Interchangeability

Jul 15 2016

How to overcome the 'double-lock' barrier to entry for generic inhalers

Jun 17 2015

EpiPen Outrage In Congress Puts Spotlight On FDA Generic Review

Aug 30 2016

FDA Biosimilar Policy Continues To Evolve With Approval Of Sandoz Erelzi

Aug 31 2016

GDUFA II Will Include Small Business Relief, Priority ANDA Reviews

Aug 31 2016

Mylan Sees A Difference In Having Generic Drug User Fees

Aug 10 2016

Mylan's Generic EpiPen: A Good PR Move, But Risks Alienating Payers

Aug 29 2016

Additional Topics

United States Drug Review Regulation Combination Products BioPharmaceutical

More from Product Reviews

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window